2711 - 2720 of 7915 Results
Title
Year
-
OPENTitle: Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trialJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 27Issue #: 8Start Page: 1451End Page: 1457Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41591-021-01455-xBest OA location URL: https://discovery.ucl.ac.uk/10134438/1/Dam%20%20%20%20PASSPORT%20Primary%20MS%20rev%20NMED-A110517A%20Final%20PIPE-18442%20w%20Figs.pdfCitation Count: 83
-
OPENTitle: Uremic Striatopallidal Syndrome Manifesting as Acute Onset ChoreaJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: S1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13285Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13285Citation Count: 2
-
OPENTitle: Use of Figurative Language by People With Parkinson Disease to Describe “Off” PeriodsJournal Name: Neurology Clinical PracticePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 11Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/cpj.0000000000001059Best OA location URL: https://cp.neurology.org/content/neurclinpract/11/4/e462.full.pdfCitation Count: 2
-
RESTRICTEDTitle: Deep brain stimulation programming strategies: segmented leads, independent current sources, and future technologyJournal Name: Expert Review of Medical DevicesPublisher: Informa UK LimitedVol: 18Issue #: 9Start Page: 875End Page: 891Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/17434440.2021.1962286Citation Count: 10
-
OPENTitle: Auditory and olfactory findings in patients with USH2A‐related retinal degeneration—Findings at baseline from the rate of progression in USH2A‐related retinal degeneration natural history study (RUSH2A)Journal Name: American Journal of Medical Genetics Part APublisher: WileyVol: 185Issue #: 12Start Page: 3717End Page: 3727Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ajmg.a.62437Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717864Citation Count: 5
-
OPENTitle: Dream Content Predicts Motor and Cognitive Decline in Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 7Start Page: 1041End Page: 1051Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13318Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13318Citation Count: 9
-
RESTRICTEDTitle: Emerging hiPSC Models for Drug Discovery in Neurodegenerative DiseasesJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 22Issue #: 15Start Page: 8196End Page: 8196Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms22158196Best OA location URL: https://www.mdpi.com/1422-0067/22/15/8196/pdf?version=1627640850Citation Count: 11
-
OPENTitle: From structure to ætiology: a new window on the biology of leucine-rich repeat kinase 2 and Parkinson's diseaseJournal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 478Issue #: 14Start Page: 2945End Page: 2951Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1042/bcj20210383Best OA location URL: https://portlandpress.com/biochemj/article-pdf/478/14/2945/918073/bcj-2021-0383.pdfCitation Count: 4
- Prognostic Modeling of Parkinson's Disease Progression Using Early Longitudinal Patterns of Change2021OPENTitle: Prognostic Modeling of Parkinson's Disease Progression Using Early Longitudinal Patterns of ChangeJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 12Start Page: 2853End Page: 2861Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28730Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688189Citation Count: 9
-
OPENTitle: The mechanisms of smell loss after SARS-CoV-2 infectionJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 20Issue #: 9Start Page: 693End Page: 695Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00202-7Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324112Citation Count: 11